PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Acmella genus plants, including A. uliginosa, demonstrate anti-inflammatory, analgesic, and anti-arthritic properties [PMID:40650269]. Leaf ethanolic and hexane-fractionated extracts significantly reduced paw volume and arthritic scores in rat models [PMID:41061997]. Flower extracts also decreased FCA-induced paw swelling in rats [PMID:27366352].
Methanolic extract of A. uliginosa flowers produced significant antinociceptive responses in both chemical and thermal-induced nociception models in mice [PMID:20920570].
Acmella genus extracts, including A. uliginosa, exhibit antibacterial potential [PMID:41836524]. Extracts from A. uliginosa showed antibacterial and antifungal activities against various strains [PMID:26817601].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34194288 (2021) — Assessment of the Diversity of Medico-Magic Knowledge on Four Herbaceous Species in Benin. · TheScientificWorldJournal
- 2.PMID: 27366352 (2016) — Assessment of anti-inflammatory and anti-arthritic properties of Acmella uliginosa (Sw.) Cass. based on experiments in arthritic rat models and qualitative gas chromatography-mass spectrometry analyses. · Journal of intercultural ethnopharmacology
- 3.PMID: 40650269 (2025) — A Systematic Review of the Potential of Acmella Genus Plants for the Treatment of Musculoskeletal Disorders. · International journal of molecular sciences
- 4.PMID: 41836524 (2026) — Exploring the Antibacterial Properties of Acmella Species: A Systematic Literature Review. · Drug design, development and therapy
- 5.PMID: 41061997